Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I study
BAT8001在HER2阳性乳腺癌患者中的安全性、耐受性和药代动力学:一项开放标签、剂量递增的I期研究
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12135
Hong, Ruoxi; Xia, Wen; Wang, Liye; Lee, Kaping; Lu, Qianyi; Jiang, Kuikui; Li, Shengfeng; Yu, Jinquan; Wei, Jin; Tang, Weijia; Zhou, Danyang; An, Xin; Huang, Jiajia; Xue, Cong; Bi, Xiwen; Shi, Yanxia; Yuan, Zhongyu; Xu, Fei; Wang, Shusen